Skip to main content
. 2020 Feb 19;10:50. doi: 10.3389/fonc.2020.00050

Table 5.

Percentage of cells with stem and EMT phenotypes among eSTCs and mSTCs.

eSTC+mSTC– (1) eSTC–mSTC+ (2) eSTC+mSTC+
eSTCs (3) mSTCs (4)
CK7+CD133Snail 70.70 (24.20–80.00) 88.10 (80.00–94.00) p1−2 = 0.031 62.70 (46.50–78.20) 73.55 (51.30–100.00)
CK7+CD133Snail+ 5.00 (1.70–7.50) 0.00 (0.00–1.40) 16.70 (6.40–24.10) 7.70 (0.00–37.45)
CK7+CD133+Snail 6.10 (0.00–19.00) 3.40 (2.00–4.50) 0.00 (0.00–8.60) 0.00
CK7+CD133+Snail+ 12.30 (9.40–29.30) 2.40 (0.00–8.50) p1−2 = 0.025 15.38 (0.00–21.60) 0.00 (0.00–3.20)
CK7+CD133N-cadherin 50.00 (17.20–73.20) 68.30 (50.0–78.10) 64.30 (51.0–66.70) 95.45 (67.85–100.00)
CK7+CD133N-cadherin+ 17.20 (15.60–33.30) 16.40 (7.30–22.70) 20.80 (13.60–33.30) 0.00 (0.00–13.65)
CK7+CD133+N-cadherin 1.20 (0.00–10.30) 1.20 (0.00–3.90) 6.60 (0.00–21.40) 0.00
CK7+CD133+N-cadherin+ 16.70 (7.70–21.70) 7.40 (0.00–12.20) p1−2 = 0.011 3.40 (0.00–17.70) 0.00 (0.00–3.05)

Percentages are given as medians and quartiles: Me (Q1–Q3). Mann–Whitney U-test. p1−2 and p3−4, differences between groups of patients with eSTCs (1) only, with mSTCs (2) only, and with eSTCs (3) and mSTCs (4) simultaneously.